Parameter | Total N = 132 (%) | Desmoplastic type n = 38 (%) | Inflammatory type n = 9 (%) | Pauci-stroma type n = 45 (%) | Sclerotic type n = 40 (%) | p value |
---|---|---|---|---|---|---|
Age (years) | Â | Â | Â | Â | Â | 0.600 |
 ≤50 | 68 (51.5) | 21 (55.3) | 5 (55.6) | 25 (55.6) | 17 (42.5) |  |
 >50 | 64 (48.5) | 17 (44.7) | 4 (44.4) | 20 (44.4) | 23 (57.5) |  |
ER | Â | Â | Â | Â | Â | 0.339 |
 Negative | 63 (47.7) | 20 (52.6) | 6 (66.7) | 22 (48.9) | 15 (37.5) |  |
 Positive | 69 (52.3) | 18 (47.4) | 3 (33.3) | 23 (51.1) | 25 (62.5) |  |
PR | Â | Â | Â | Â | Â | 0.060 |
 Negative | 91 (68.9) | 28 (73.7) | 7 (77.8) | 35 (77.8) | 21 (52.5) |  |
 Positive | 41 (31.1) | 10 (26.3) | 2 (22.2) | 10 (22.2) | 19 (47.5) |  |
HER-2 | Â | Â | Â | Â | Â | 0.370 |
 Negative | 89 (67.4) | 28 (73.7) | 4 (44.4) | 29 (64.4) | 28 (70.0) |  |
 Positive | 43 (32.6) | 10 (26.3) | 5 (55.6) | 16 (35.6) | 12 (30.0) |  |
Molecular subtypes | Â | Â | Â | Â | Â | 0.063 |
 Luminal A | 47 (35.6) | 15 (39.5) | 3 (33.3) | 12 (26.7) | 17 (42.5) |  |
 Luminal B | 23 (17.4) | 3 (7.9) | 0 (0.0) | 11 (24.4) | 9 (22.5) |  |
 HER-2 | 27 (20.5) | 7 (18.4) | 5 (55.6) | 8 (17.8) | 7 (17.5) |  |
 TNBC | 35 (26.5) | 13 (34.2) | 1 (11.1) | 14 (31.1) | 7 (17.5) |  |
Ki-67 LI (%) | Â | Â | Â | Â | Â | 0.139 |
 ≤14 | 91 (68.9) | 31 (81.6) | 6 (66.7) | 26 (57.8) | 28 (70.0) |  |
 >14 | 41 (31.1) | 7 (18.4) | 3 (33.3) | 19 (42.2) | 12 (30.0) |  |
Metastasis site | Â | Â | Â | Â | Â | < 0.001 |
 Bone | 32 (24.2) | 18 (47.4) | 0 (0.0) | 4 (8.9) | 10 (25.0) |  |
 Brain | 38 (28.8) | 3 (7.9) | 2 (22.2) | 25 (55.6) | 8 (20.0) |  |
 Liver | 10 (7.6) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 10 (25.0) |  |
 Lung | 52 (39.4) | 17 (44.7) | 7 (77.8) | 16 (35.6) | 12 (30.0) |  |
Patients death | 44 (33.3) | 15 (39.5) | 3 (33.3) | 14 (31.1) | 12 (30.0) | 0.815 |